Charles Schwab Investment Management Inc. Grows Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Charles Schwab Investment Management Inc. grew its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 11.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 48,625 shares of the company’s stock after purchasing an additional 4,802 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.52% of Semler Scientific worth $2,626,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Shariaportfolio Inc. boosted its holdings in Semler Scientific by 4.5% during the fourth quarter. Shariaportfolio Inc. now owns 160,453 shares of the company’s stock worth $8,664,000 after buying an additional 6,837 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Semler Scientific by 10.5% during the 3rd quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock worth $3,202,000 after acquiring an additional 12,964 shares in the last quarter. State Street Corp grew its holdings in shares of Semler Scientific by 0.6% in the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after acquiring an additional 725 shares during the period. Principal Financial Group Inc. increased its stake in Semler Scientific by 633.1% in the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company’s stock valued at $6,074,000 after purchasing an additional 97,144 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its holdings in Semler Scientific by 345.8% during the fourth quarter. Exchange Traded Concepts LLC now owns 61,396 shares of the company’s stock worth $3,315,000 after purchasing an additional 47,625 shares during the last quarter. 49.37% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Lake Street Capital upped their target price on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a report on Friday, January 24th.

Semler Scientific Price Performance

SMLR stock opened at $36.92 on Friday. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $81.56. The company’s 50 day simple moving average is $46.02 and its 200-day simple moving average is $44.53. The firm has a market capitalization of $354.32 million, a PE ratio of 7.52 and a beta of 1.33.

Semler Scientific (NASDAQ:SMLR) last released its earnings results on Tuesday, February 18th. The company reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. The company had revenue of $12.41 million for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.